A better way to LIMS: biology's modern solution
Legacy LIMS are overly rigid, costly, onerous to maintain, and built for chemistry, not modern biology. Outdated LIMS solutions cannot efficiently support the complexity of managing R&D for cell and gene therapies, antibody-drug conjugates, and RNA therapeutics. These modalities require advanced, built-for-biology software to process, analyze, and scale novel biomolecules into marketable products.
This whitepaper breaks down:
The challenges of using legacy LIMS in today’s world
The full lifecycle benefits of Benchling’s modern LIMS
Key features and use cases for Benchling’s modern LIMS solution
Join over 200,000 scientists using Benchling to power their biotech R&D